EUDA Health Holdings Limited

EUDA Real Estate Real Estate Services

EUDA Health Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 70.0% from fiscal 2024.

15.40 0.09 −0.58%
Market cap
$46.3M
P/E
0.0×
Fwd P/E
10.0×
Dividend yield
—
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 46.32
Revenue —
Net Income (45.31)
Free Cash Flow (4.52)
Net Debt (7.89)
Current Ratio 2.53
Debt/Equity 0.01
P/E ratio 0.00
Fwd P/E 10.00
P/S ratio 0.00
P/B ratio 2.61
Past 5Y EPS Growth —
This Y EPS Growth 900.00% (at or above 15%: strong)
Next Y EPS Growth 209.09% (at or above 15%: strong)
Next Y revenue growth 299.25% (at or above 10%: strong)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 0 0 0 8
Receivables 0 0 0 1
Inventory — 0 0 0
Other — — — —
1 1 1 9
2023 2024 2025 Q'26
Payables 0 1 1 0
ST’ Debt 1 1 2 0
Other — 0 1 0
9 4 6 4

Compound Annual Growth %

10y 5y 3y
Sales — (8.35%) 21.91%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — 7
’24 — — — — 4
’23 2 — — — 4
’22 — — — — 4
’22 3 — — — 10
’21 — — — — 11
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Jan Mar Apr Jul Year
’26 — — — — —
’25 — — — — (2)
’24 — — — — (2)
’23 — 0 — — (3)
’22 — — — — (2)
’22 0 0 (1) 0 (2)
’21 — — — — 0
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Jan Mar Apr Jul Year
’26 — — — — —
’25 — — — — (3)
’24 — — — — (2)
’23 — 0 — — (3)
’22 — — — — (2)
’22 0 0 (1) 0 (2)
’21 — — — — 0
Fiscal quarters ending in the months shown.

EPS $

Jan Mar Apr Jul Year
’26 — — — — —
’25 — — — — (1.48)
’24 — — — — (9.40)
’23 — (2.40) — — (8.80)
’22 — — — — (41.48)
’22 (0.02) 0.49 (0.04) (0.09) (2.07)
’21 — — — — 1.95
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — 193.00 25.20 8.66 24.00 20.60

Analyst estimates 2026–2028

Powerpack
High — — — — — 195.20 210.00 68.80 126.00 93.90
People
People Employees — — — — — — 150 106 117 123
Revenue/emp, $m — — — — — 0.00 0.03 0.03 0.03 0.06
Income, $m
Income, $m Revenue — — — — — 11 4 4 4 7
Gross margin, % — — — — — 40.25 23.11 22.72 19.00 43.88
EBT — — — — — 1 (25) (8) (18) (3)
EBT margin, % — — — — — 9.00 (664.90) (227.57) (439.85) (39.97)
Net income — 0 — — — 1 (25) (8) (18) (3)
Depreciation — — — — — 0 0 0 0 0
Per share, $
Per share, $ Revenue — — — — — 22.79 6.26 3.24 2.47 3.65
Earnings — — — — — 1.95 (37.27) (8.80) (9.40) (1.48)
Cash flow — — — — — 0.96 (2.54) (2.55) (1.25) (1.30)
Capex — — — — — 0.00 (0.03) 0.00 (0.07) (0.06)
Free cash flow — — — — — 0.96 (2.57) (2.55) (1.33) (1.35)
Book value — — — — — 1.30 (5.83) (6.53) (1.58) (2.28)
Shares, m — — — — — 0 1 1 2 2
Valuation, ×
Valuation, × P/E — — — — — 0.00 86.63 0.00 0.00 0.00
P/S — — — — — 0.00 0.00 0.00 0.00 0.00
P/B — — — — — 3,133.52 0.00 0.00 0.00 0.00
EV/Sales — — — — — 0.00 0.00 0.00 0.00 0.00
EV/FCF — — — — — 0.00 (142.60) (12.59) (26.72) (10.74)
Cash, $m
Cash, $m Operating cash flow — — — — — 0 (2) (3) (2) (2)
Capex — — — — — 0 0 — 0 0
Free cash flow — — — — — 0 (2) (3) (2) (3)
Balance, $m
Balance, $m Working capital — — — — — (3) (4) (8) (3) (5)
Total debt — — — — — 0 0 1 1 2
Net debt — — — — — 0 0 1 1 2
Shareholders’ equity — — — — — 1 (4) (7) (3) (4)
Returns, %
Returns, % ROA — — — — — 10.81 (97.09) (74.53) (1,020.99) (162.42)
ROIC — — — — — (98.27) 0.00 0.00 0.00 0.00
ROE — — — — — 154.25 708.19 182.72 305.49 81.08
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Mar 2023 · fundamentals updated 1 Oct 2026

Charts ten years each

EUDA Health Holdings Limited vs peers in Real Estate Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
STHO Star Holdings $96.8M 6.4× — −53.96% (below 0%: shrinking) n/m −263.07% (below 0%: shrinking) 27.41% 9.47% Compare
SRG Seritage Growth Properties $92.9M — (loss-making) 10.8× −59.72% (below 0%: shrinking) n/m +10.60% (above 0%: growing) 38.90% (253.84%) Compare
MAYS J. W. Mays, Inc. $79.9M — (loss-making) — (loss-making) −5.64% (below 0%: shrinking) n/m −250.78% (below 0%: shrinking) 24.74% (6.05%) Compare
RFL Rafael Holdings, Inc. $76.5M — (loss-making) — (loss-making) −50.55% (below 0%: shrinking) n/m −128.22% (below 0%: shrinking) 95.53% (3,837.99%) Compare
ASPS Altisource Portfolio Solutions S.A. $63.8M — (loss-making) — (loss-making) +17.04% (above 0%: growing) n/m −2,120.39% (below 0%: shrinking) 25.30% 2.23% Compare
EUDA EUDA Health Holdings Limited $46.3M — (loss-making) 10.0× — n/m −881.74% (below 0%: shrinking) 26.92% 0.00%
MDRR Medalist Diversified REIT, Inc. $24.1M 1.7× — (loss-making) −26.64% (below 0%: shrinking) n/m +144.90% (above 0%: growing) 64.43% (21.79%) Compare
DUO Fangdd Network Group $22.6M — (loss-making) — (loss-making) −15.35% (below 0%: shrinking) n/m +49.62% (above 0%: growing) 12.91% 0.00% Compare
NYC American Strategic Investment Co. $18.5M 1.2× — (loss-making) −40.15% (below 0%: shrinking) n/m +98.49% (above 0%: growing) 16.69% (26.47%) Compare
Median of peers $70.2M 1.7× — −33.39% — −58.81% 26.36% (13.92%)

All 46 Real Estate Services stocks →

EUDA Health Holdings Limited (EUDA) key facts

  • Strength: EUDA Health Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 70.0% from fiscal 2024.
  • EUDA Health Holdings Limited (EUDA) is a Real Estate Services company in the Real Estate sector, listed on Nasdaq.
  • As of October 16, 2026, EUDA traded at $15.40, a market capitalization of $46.3 million.
  • Return on equity was 81.1% and debt-to-equity 0.01.
  • Its Piotroski F-score is 5 out of 9 for fiscal 2025.

Source: company filings (standardised) and stockrow calculations · fundamentals updated Oct 1, 2026.

EUDA Health Holdings Limited (EUDA) Latest News

22 Dec

Impact 3 ·
stockrow.com/EUDA · Data as of Oct 1, 2026 · For information only; not investment advice. · © 2026 stockrow.com